Canada’s biotechnology sector is generating significant scientific and economic value, but the bigger question is where that value will ultimately be captured.

In a new Hill Times op-ed, we look at what it will take to ensure more Canadian biotechnology companies can grow, commercialize and create lasting value here at home, while helping new innovations reach patients.